Sanlam has written its AfroCentric stake down to nil after the Bonitas exit but rules out a sale, betting it can revive the business.
You must be a subscriber to access all of this content.
GLP-1 medicines alone can't solve SA's diabetes crisis, experts warn, urging earlier screening, coordinated care and better food access.
You must be a subscriber to access all of this content.
Aspen's turnaround hinges on filling its underused sterile manufacturing plants, as GLP-1 sales drive a share recovery.
You must be a subscriber to access all of this content.
Dr Thembisile Xulu is the new health Director-General, inheriting a strained department, healthcare-worker shortages and NHI litigation.
You must be a subscriber to access all of this content.
Gauteng is losing 100 nurses a month and needs R5.7bn to fill a 16,000-post gap. This shortage now flagged as a key risk to the NHI rollout.
You must be a subscriber to access all of this content.
Regulation, not demand, blocks affordable cover: medical schemes should be allowed to offer low-cost benefit options (LCBOs) now.
You must be a subscriber to access all of this content.